Elevated Levels of Interleukin-18 Are Associated with Several Indices of General and Visceral Adiposity and Insulin Resistance in Women with Polycystic Ovary Syndrome

Overview

Journal Arch Endocrinol Metab

Specialty Endocrinology

Date 2022 Mar 9

PMID 35263047

Authors

Plamena Kabakchieva

Antoaneta Gateva

Tsvetelina Velikova

Tsvetoslav Georgiev

Kyosuke Yamanishi

Haruki Okamura

Zdravko Kamenov

Affiliations

Soon will be listed here.

Abstract

Objective: Our aim was to analyze levels of proinflammatory biomarker interleukin-18 (IL-18) in healthy controls and patients with polycystic ovary syndrome (PCOS) focusing on its association with obesity, clinical, hormonal, and metabolic characteristics.

Methods: Fifty-eight patients with PCOS were enrolled in the study fulfilling the Rotterdam criteria and were matched for age, body mass index (BMI), and ethnicity with 30 healthy controls. Detailed anthropometric measurements, clinical investigations, hormonal and biochemical tests were obtained between the 3 and 5 day of a menstrual cycle. A subanalysis of the PCOS group was performed separating patients into several groups according to a waist-to-height ratio (WHtR), insulin resistance (IR), and free androgen index (FAI). Serum IL-18 levels were measured using the ELISA method.

Results: Levels of IL-18 were similar between PCOS patients and controls. IL-18 was higher in overweight/obese women compared to normal-weight women when analyzing all participants together and separately PCOS or controls group (p < 0.001, p < 0.001, p = 0.01, respectively). Additionally, IL-18 levels were higher in high-WHtR and IR subgroups compared to low-WHtR (p < 0.001) and non-IR PCOS women (p < 0.001). PCOS women with high FAI had greater serum IL-18 levels than normal-FAI patients (p = 0.002). Levels of IL-18 correlated positively with most of the anthropometric and metabolic parameters. In multiple linear regression, age, waist circumference, and fasting insulin were independently related factors with IL-18.

Conclusion: Elevated levels of IL-18 were related to several indices of general and visceral adiposity and insulin resistance in PCOS.

Citing Articles

Interaction of obesity and proteins associated with the NLRP3 inflammasome following mild traumatic brain injury.

Eagle S, Basantani M, Preszler J, Sherry N, McIntyre P, Kershaw E Sci Rep. 2024; 14(1):10178.

PMID: 38702410 PMC: 11068868. DOI: 10.1038/s41598-024-61089-0.

Mechanisms and Target Parameters in Relation to Polycystic Ovary Syndrome and Physical Exercise: Focus on the Master Triad of Hormonal Changes, Oxidative Stress, and Inflammation.

Lorincz C, Borzsei D, Hoffmann A, Varga C, Szabo R Biomedicines. 2024; 12(3).

PMID: 38540173 PMC: 10968456. DOI: 10.3390/biomedicines12030560.

Meteorin-like Protein and Zonulin in Polycystic Ovary Syndrome: Exploring Associations with Obesity, Metabolic Parameters, and Inflammation.

Kabakchieva P, Gateva A, Velikova T, Georgiev T, Yamanishi K, Okamura H Biomedicines. 2024; 12(1).

PMID: 38275393 PMC: 10813337. DOI: 10.3390/biomedicines12010222.

Molecular Mechanisms of IL18 in Disease.

Yamanishi K, Hata M, Gamachi N, Watanabe Y, Yamanishi C, Okamura H Int J Mol Sci. 2023; 24(24).

PMID: 38139000 PMC: 10743479. DOI: 10.3390/ijms242417170.

Hepatic steatosis in women with polycystic ovary syndrome.

Hong X, Guo Z, Yu Q BMC Endocr Disord. 2023; 23(1):207.

PMID: 37752440 PMC: 10521461. DOI: 10.1186/s12902-023-01456-6.

References

Zhang Y, Yang Y, Hong J, Gu W, Shen C, Xu M . Elevated serum levels of interleukin-18 are associated with insulin resistance in women with polycystic ovary syndrome. Endocrine. 2006; 29(3):419-23. DOI: 10.1385/ENDO:29:3:419. View

Condorelli R, Calogero A, DI Mauro M, Mongioi L, Cannarella R, Rosta G . Androgen excess and metabolic disorders in women with PCOS: beyond the body mass index. J Endocrinol Invest. 2017; 41(4):383-388. DOI: 10.1007/s40618-017-0762-3. View

Lindholm A, Blomquist C, Bixo M, Dahlbom I, Hansson T, Poromaa I . No difference in markers of adipose tissue inflammation between overweight women with polycystic ovary syndrome and weight-matched controls. Hum Reprod. 2011; 26(6):1478-85. PMC: 3096560. DOI: 10.1093/humrep/der096. View

Jung U, Choi M . Obesity and its metabolic complications: the role of adipokines and the relationship between obesity, inflammation, insulin resistance, dyslipidemia and nonalcoholic fatty liver disease. Int J Mol Sci. 2014; 15(4):6184-223. PMC: 4013623. DOI: 10.3390/ijms15046184. View

Zaharieva E, Kamenov Z, Velikova T, Tsakova A, El-Darawish Y, Okamura H . Interleukin-18 serum level is elevated in type 2 diabetes and latent autoimmune diabetes. Endocr Connect. 2017; 7(1):179-185. PMC: 5776671. DOI: 10.1530/EC-17-0273. View

. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2003; 19(1):41-7. DOI: 10.1093/humrep/deh098. View

Esposito K, Pontillo A, Ciotola M, Di Palo C, Grella E, Nicoletti G . Weight loss reduces interleukin-18 levels in obese women. J Clin Endocrinol Metab. 2002; 87(8):3864-6. DOI: 10.1210/jcem.87.8.8781. View

Sirmans S, Parish R, Blake S, Wang X . Epidemiology and comorbidities of polycystic ovary syndrome in an indigent population. J Investig Med. 2014; 62(6):868-74. DOI: 10.1097/01.JIM.0000446834.90599.5d. View

Escobar-Morreale H, Botella-Carretero J, Villuendas G, Sancho J, San Millan J . Serum interleukin-18 concentrations are increased in the polycystic ovary syndrome: relationship to insulin resistance and to obesity. J Clin Endocrinol Metab. 2004; 89(2):806-11. DOI: 10.1210/jc.2003-031365. View

10.

Zeyda M, Huber J, Prager G, Stulnig T . Inflammation correlates with markers of T-cell subsets including regulatory T cells in adipose tissue from obese patients. Obesity (Silver Spring). 2010; 19(4):743-8. DOI: 10.1038/oby.2010.123. View

11.

Ashwell M, Hsieh S . Six reasons why the waist-to-height ratio is a rapid and effective global indicator for health risks of obesity and how its use could simplify the international public health message on obesity. Int J Food Sci Nutr. 2005; 56(5):303-7. DOI: 10.1080/09637480500195066. View

12.

Bahceci E, Kaya C, Karakas S, Yildiz S, Hosgoren M, Ekin M . Serum X-box-binding protein 1 levels in PCOS patients. Gynecol Endocrinol. 2021; 37(10):920-924. DOI: 10.1080/09513590.2021.1942449. View

13.

Wentworth J, Naselli G, Brown W, Doyle L, Phipson B, Smyth G . Pro-inflammatory CD11c+CD206+ adipose tissue macrophages are associated with insulin resistance in human obesity. Diabetes. 2010; 59(7):1648-56. PMC: 2889764. DOI: 10.2337/db09-0287. View

14.

Elci E, Kaya C, Cim N, Yildizhan R, Gunes Elci G . Evaluation of cardiac risk marker levels in obese and non-obese patients with polycystic ovaries. Gynecol Endocrinol. 2016; 33(1):43-47. DOI: 10.1080/09513590.2016.1203893. View

15.

Evans J, Collins M, Jennings C, van der Merwe L, Soderstrom I, Olsson T . The association of interleukin-18 genotype and serum levels with metabolic risk factors for cardiovascular disease. Eur J Endocrinol. 2007; 157(5):633-40. DOI: 10.1530/EJE-07-0463. View

16.

Duleba A, Dokras A . Is PCOS an inflammatory process?. Fertil Steril. 2011; 97(1):7-12. PMC: 3245829. DOI: 10.1016/j.fertnstert.2011.11.023. View

17.

Angelova P, Kamenov Z, Tsakova A, El-Darawish Y, Okamura H . Interleukin-18 and testosterone levels in men with metabolic syndrome. Aging Male. 2017; 21(2):130-137. DOI: 10.1080/13685538.2017.1401993. View

18.

Gateva A, Kamenov Z . Markers of visceral obesity and cardiovascular risk in patients with polycystic ovarian syndrome. Eur J Obstet Gynecol Reprod Biol. 2012; 164(2):161-6. DOI: 10.1016/j.ejogrb.2012.05.037. View

19.

Dawood A, Alkafrawy N, Saleh S, Noreldin R, Zewain S . The relationship between IL-18 and atherosclerotic cardiovascular risk in Egyptian lean women with polycystic ovary syndrome. Gynecol Endocrinol. 2017; 34(4):294-297. DOI: 10.1080/09513590.2017.1395835. View

20.

Cardoso N, Ribeiro V, Dutra S, Ferriani R, Gastaldi A, de Araujo J . Polycystic ovary syndrome associated with increased adiposity interferes with serum levels of TNF-alpha and IL-6 differently from leptin and adiponectin. Arch Endocrinol Metab. 2020; 64(1):4-10. PMC: 10522288. DOI: 10.20945/2359-3997000000197. View